Alembic has demonstrated a culture of manufacturing excellence since inception. Our portfolio of world-class facilities delivers innovation at scale. We make continuous efforts in enhancing and upgrading these facilities through focused investments and targeted improvements. Skill development of our people is a priority for us. It ensures that our facilities keep producing at the highest levels of efficiency, scale and excellence. Our plants are designed to maintain uncompromised quality, and stringent compliance. Our agile manufacturing processes help meet evolving market demands.
Formulations facilities
(5 in Gujarat, 1 in Sikkim)
APIs manufacturing
facilities (Gujarat)
| Location | Dosage Form | Audit/Filing status |
|---|---|---|
International Generics |
||
| F1 - Panelav | General Oral Solids |
March 2020* |
| F2 - Panelav | Oncology Oral Solids Oncology Injectables |
June 2019* |
| F3 - Karkhadi | General Injectables Ophthalmic |
February 2021# |
| F4 - Jarod | General Oral Solids |
June 2020 |
| Aleor (JV) - Karkhadi | Various derma forms |
January 2020* |
API |
||
| API I & II - Panelav | December 2018* |
|
| API III - Karkhadi | January 2020* |
|
* Last USFDA Inspection
Filing/Expected filing
F2- Oncology OSD
F2 Oncology injectable
F3 General Injectable & Opthalmic
F4-New oral solids
